Quest Diagnostics Incorporated Stock price

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
128.1 USD -0.11% Intraday chart for Quest Diagnostics Incorporated -1.00% -7.06%
Sales 2024 * 9.4B Sales 2025 * 9.72B Capitalization 14.19B
Net income 2024 * 886M Net income 2025 * 955M EV / Sales 2024 * 1.91 x
Net Debt 2024 * 3.77B Net Debt 2025 * 3.18B EV / Sales 2025 * 1.79 x
P/E ratio 2024 *
16.5 x
P/E ratio 2025 *
15.1 x
Employees 44,000
Yield 2024 *
2.26%
Yield 2025 *
2.33%
Free-Float 68.04%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Quest Diagnostics Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:15 AM
Quest Diagnostics Insider Sold Shares Worth $852,769, According to a Recent SEC Filing MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target MT
Quest Diagnostics Incorporated acquired Assets from Lenco Diagnostic Laboratories Inc. for approximately $110 million. CI
Quest Diagnostics' Pack Health, Instacart to Combine Grocery Delivery With Nutrition Coaching Services MT
The fate of the market depends on this Our Logo
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Our Logo
Correction: Quest Diagnostics Participates in Freenome's $254 Million Financing MT
Quest Diagnostics Participates in Freenome's $254 Million Financing MT
Freenome Holdings, Inc. announced that it has received $254 million in funding from a group of investors CI
Quest Diagnostics Incorporated Announces the Launch of MelaNodal Predict CI
Quest Diagnostics Incorporated Announces the Availability of the First Consumer-Initiated, Physician-Ordered Blood-Draw Test for PFAS Chemicals CI
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140 MT
Fed officials fail to convince investors, who are focused on earnings Our Logo
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile... Our Logo
More news
1 day-0.11%
1 week-1.00%
Current month+2.60%
1 month+3.34%
3 months-5.65%
6 months+1.87%
Current year-7.06%
More quotes
1 week
125.09
Extreme 125.09
131.26
1 month
123.30
Extreme 123.3
131.26
Current year
123.04
Extreme 123.04
143.63
1 year
119.59
Extreme 119.59
148.62
3 years
119.59
Extreme 119.59
174.16
5 years
73.02
Extreme 73.02
174.16
10 years
54.62
Extreme 54.615
174.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 13-03-31
Director of Finance/CFO 54 22-07-10
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 19-02-17
Director/Board Member 67 11-12-06
Director/Board Member 80 96-12-31
More insiders
Date Price Change Volume
24-03-18 128.1 -0.11% 838,241
24-03-15 128.3 +0.91% 1,954,928
24-03-14 127.1 -1.77% 1,018,880
24-03-13 129.4 -0.25% 849,373
24-03-12 129.7 +0.24% 909,214

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
128.1 USD
Average target price
141.8 USD
Spread / Average Target
+10.65%
Consensus
  1. Stock
  2. Equities
  3. Stock Quest Diagnostics Incorporated - Nyse